Navigation Links
Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
Date:2/5/2008

/p>

impact (0.01)(A) (0.01)(A) (0.01)(A) (0.01)(A)

Diluted net income per

share on a non-GAAP

basis $0.11 $0.13 $0.33 $0.37

Shares used in

calculation of diluted

net income per share --

GAAP 55,220 53,074 54,789 53,270

Shares used in

calculation of diluted

net income per share --

Non-GAAP 62,511 60,365 62,080 60,561

(A) The company's total diluted share count on a non-GAAP basis in 2007

and 2006 on YTD and QTD basis includes approximately 7.3 million

shares underlying its convertible notes as they were dilutive for

both the quarter and YTD.

The following table reconciles the specific items excluded from GAAP gross profit and gross margin in the calculation of non-GAAP gross profit and gross margin for the periods shown below:

THORATEC CORPORATION

Reconciliation of GAAP to Non-GAAP Gross Profit

(Unaudited)

(in thousands, except for per share data)

Three Months Ended For the Fiscal Year Ended

December 29, December 31, December 29, December 31,

2007 2006 2007 2006

(in

thousands)

Gross

profit

on a

GAAP

basis $35,718 55.7% $35,040 59.5% $136,264 58.0% $125,485 58.6%

Share

-based

compen-

sation

expense 405 12 1,598 1,000

Inventory

Backlog - 100 - 100 Gross profit

on a

non-GAAP

basis $36,123 56.4% $35,152 59.7% $137,862 58.7% $126,585 59.1%

The following tables reconcile the
'/>"/>

SOURCE Thoratec Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Thoratec Presentation at JP Morgan Conference to be Webcast
2. Thoratec Announces Appointment of Steven H. Collis to Board of Directors
3. Thoratec Presentation at Bear Stearns Conference To Be Webcast
4. Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
5. Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter
6. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
7. CuraGen Reports Fourth Quarter and Year End 2007 Financial Results
8. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
9. Phosphagenics Reports Superior Pre-clinical Cholesterol Results from APA-01 and Atorvastatin Combination
10. Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data
11. Millennium Biotechnologies Group Reports 40% Sales Increase for Resurgex Product Line in Greek Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Chester, NJ (PRWEB) August 21, 2014 ... of personal selling optimization technology and services for ... publication of “Grading Pharma’s Use of New Commercial ... of Measurement & Analytics. , The article examines ... marketing yield that are being tested in the ...
(Date:8/20/2014)... Aug. 20, 2014 Clintrax Global, Inc., ... in Raleigh, NC , recently ... as Vice President of Administration. ... all corporate processes, including their alignment with company ... Brad worked as an HR executive, specializing in ...
(Date:8/20/2014)... High performance computing (HPC) will ... complete climate and Earth system model to address ... , Eight national laboratories, including Lawrence Livermore ... for Atmospheric Research, four academic institutions and one ... national laboratories include Argonne, Brookhaven, Lawrence Berkeley, Los ...
(Date:8/20/2014)... 2014 /PRNewswire-iReach/ -- A case study from Intel ... school,s bioengineering department and the Intel® Internet of ... Academic Program, UCSD,s research focuses on exploring the ... Photo - http://photos.prnewswire.com/prnh/20140819/137540 ... of Dr. Todd P. Coleman , Associate ...
Breaking Biology Technology:Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2Clintrax Global, Inc. Announces Addition to Executive Team 2New Project Is the ACME of Addressing Climate Change 2New Project Is the ACME of Addressing Climate Change 3Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research 2
... today announced the,publication of an independent, peer reviewed, ... immune response measured prior to kidney,transplantation using the ... to identify patients that may be at risk ... in the first three,months following transplantation., The ...
... Naval Academy satellite called MidSTAR-1 have proven successful in ... that can check for harmful chemicals and the other ... These technologies were collaboratively developed between NASAs Goddard Space ... Field, Calif.; and Eclipse Energy Systems Inc. of various ...
... Brinks Hofer Gilson & Lione, one of,the largest ... to announce that Meredith Martin Addy has been named ... practice areas by Law & Politics,magazine., Intellectual property ... However, in fourteen years of practice, Ms. Addy is,among ...
Cached Biology Technology:New Independent Research Study Indicates That Cylex's ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection 2New Independent Research Study Indicates That Cylex's ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection 3NASA MidSTAR-1 successful technologies may be revolutionary 2NASA MidSTAR-1 successful technologies may be revolutionary 3NASA MidSTAR-1 successful technologies may be revolutionary 4Meredith Martin Addy Named One of Top 10 Illinois 'Super Lawyers' for 2008 2
(Date:8/20/2014)... 20, 2014 /CNW/ -  Issue Serious ... quickly become life threatening for some children.    ... million Canadians have food allergies and this number may be ... children are estimated to have food allergies.  ... irritations and hives to breathing difficulties and loss of consciousness. ...
(Date:8/20/2014)... in this image of the Para and Mato Grosso ... likely intentionally set in order to deforest the land. ... of trees where the land is thereafter converted to ... forestland to farms, ranches, or urban use. The herringbone-patterned ... Amazon Rainforest in the middle of the image are ...
(Date:8/20/2014)... Bay Area Lyme Foundation, which aims to make Lyme ... new research published in an upcoming issue of the ... . The findings show that ticks that carry ... year, making the threat of Lyme disease year-round. The ... Public Health (CDPH) Vector-borne Disease Section and University of ...
Breaking Biology News(10 mins):Information Update - Allergens and food safety at school - What's in your child's lunch? 2Information Update - Allergens and food safety at school - What's in your child's lunch? 3Lyme disease risk is year-round in Northwest California, according to new study 2Lyme disease risk is year-round in Northwest California, according to new study 3
... compounds beginning in early adulthood may delay the onset ... Wake Forest University School of Medicine and other centers ... the Endocrine Society, in San Diego. , Suppression of ... decrease cancer risk in those individuals at high risk ...
... University chemists have employed a computer simulation whose ... transcription process. The study, funded by the National ... issue of the Proceedings of the National Academy ... chromatin--a chromosome's substance consisting of histone proteins and ...
... can create tiny sensors with abilities to detect odors ... Pennsylvania and Monell Chemical Sciences Center. Their findings are ... Letters, a publication of the American Chemical Society. , ... detect molecules on the order of one part per ...
Cached Biology News:Suppressing growth hormone in early adulthood may prevent cancer 2Researchers Create DNA-Based Sensors for Nano-Tongues and Nano-Noses 2
Mouse monoclonal [H4B4] to LAMP2 - Lysosome Marker (Phycoerythrin) ( Abpromise for all tested applications). entrezGeneID: 3920 SwissProtID: P13473...
Mouse monoclonal [IA-C6] to MHC Class II I Ab + Ad (FITC) ( Abpromise for all tested applications). Antigen: Tissue / cell preparation of Purified Mouse lymph node B cells...
...
... Ciphergens ProteinChip System, Series 4000 incorporates the ... researchers and biologists in biomarker research. The ... fastest route for converting biomarker discoveries to ... The Series 4000 is designed to fit ...
Biology Products: